LATE DIAGNOSIS OF BEHc¸ET'S PATIENT WITH SCLERITIS
Introduction: Behc¸et's disease (BD) is a systemic inflammatory disorder that was originally described by Hulusi Behc¸et in 1937, as a triad of recurrent genital and oral ulcers, as well as iritis.BDhasoften also been referred to as the silk-road disease, due to the usual geographical distribution of the disease along the silk route, with a greater prevalence in Turkey. BD is characterised by recurrent oro-genital ulceration, alongside variable ocular, vascular and pulmonary manifestations. Ocular involvement is seen inaround70% of BDpatientsand usually occurs after the manifestation of oral and genital ulcers. Only 20% of BD patients experience ocular involvement as the initial manifestation. The most common ocular manifestation is uveitis. However, there are some uncommon ocular manifestations too, including conjunctivitis, episcleritis and scleritis. Scleritis is a severe ocular inflammatorydisorder,which hasbeenknown tobe associated with conditions such as rheumatoid arthritis (RA). However, it is very rarely associated with BD. Although BD is identified using the International Study Group criteria, where the presence of recurrent oral ulcers along with any two of genital ulcers, eye lesions, skin lesions and a positive pathergy test are diagnostic of BD, there is no mention of genetic markers in the criteria. However, HLA-B51 has been shown to be present in over two thirds of BD patients. This case report describes a late diagnosis of BD in apatient who developed scleritis. Casedescription:YYisa40yearoldmaleofFrenchoriginwhopresented with episcleritis in his left eye in 2004. This subsequently settled. However, he then developed diffuse anterior/posterior scleritis in his right eye in2005. He was treatedwith prednisoloneand again thingsseemedto settle. In 2006, he was diagnosed with reactive right knee arthropathy and was prescribed methotrexate. In 2008, YY relapsed; presented with complaints of photophobia, discomfort and redness in his right eye and was again diagnosed with active scleritis. He was prescribed prednisolone and ketorolac. Although his ocular symptoms seemed to improve, it was noticed that relapsed as soon as he missed his prednisolone tablets. In 2009, he presented to the rheumatology clinic with a rash all over his legs. He seemed very concerned about his right knee, the rash all over his legs and his right eye. It was found that he may be allergic to methotrexate and it was stopped immediately, but this did not improve the rash. In fact, it got worse and spread to his groin and abdomen, as well as to the dorsum of his feet. Blood tests showed leucocytosis, whereas CRP and ESR were normal. With regards to his knee, no definitive diagnosis was made. As he presented with several features of spondyloarthopathy, it was thought he may have psoriatic arthritis. In the meantime, it became a struggle to control the scleritis. YY was given IV cyclophosphamide but his arthropathy did not respond. In 2010, a positive HLA-B51 result was found, which pointed to a possible diagnosis of BD. He was started on thalidomide, followed by infliximab and then rituximab. This seemed to have no effect and he stopped attending clinic. He was then referred to the department in 2017 as a new referral and it was only then that a formal diagnosis of Behc¸et's-related scleritis was made. Since then his condition is being managed, with efforts to try to wean him off prednisolone and for him to lose weight. He has also commenced a wheat-free diet. With a retrospectivelookathishistory,itwasfoundthat2004,theyearhehadhisfirstattack of scleritis, was the worst year of his life. Not only did he go through a messy divorce, he also went through a financial crisis. This was extremely stressful andmayhave been apotential triggerforhis BDscleritis. Discussion: Scleritis is a rare ocular manifestation of BD, but it is important that it is not missed. In this case, it wasn't until a positive HLA-B51 result came through that a definitive diagnosis was made. If this had been made earlier, he could have been treated better and gone through a less stressfultime because of his condition. Key Learning Points: HLA-B51 is a key diagnostic tool in the diagnosis of BD. It is important that patientsarescreenedcarefully and thattheir symptoms are investigated thoroughly to speed up diagnosis. Even if a rare manifestation presents, it should not be ignored. In addition, stress is a key trigger for BD which should always be investigated in such patients to avoid making a late diagnosis. The diagnosis of lupus can be easily made in patients whose symptoms fit the diagnostic criteria, however it can be sometimes challenging particularly whenpatientspresents atypically, in which cases rheumatologists need to differentiate between real disease versus other differentials of lupus-like syndromes. Herein we describe a challenging case of patients who was referred to rheumatology with lupus like syndrome, and outline the lesson drawn from this case. Case description: This is a case of 49 year old lady. mother of two, Usually fit and well, referred to rheumatology in November 2017 with six months history of: arthralgia, myalgia and constitutional symptoms. She also had history of iron deficiency aneamia which was thought secondary to polyp which was removed. Blood tests orgnaised byGP showed raised CRP of 35, RF: 39 and normocytic anaemia with Hb of 90. During rheumatology review, the patient described an episode of viral illness and subsequent symptoms of tiredness, lethargy, arthralgia, night sweats/ hot flashes. she denied any skin rashes/mouth ulcers/hair loss/Raynaud's. She described finger nail changes which were not present during the clinic consultation. She stopped having periods in April 2017. Her symptoms were initially attributed to peri menopausal syndrome. physical examination was unremarkable except mild ankle swelling. Blood results showed raised CRP: 35, normocytic anaemia, leucopenia og 5 and lymphopenia of 0.7. Blood tests showed raised RF: 39, negative ANA, CCP, unremarkable serum electrophoresis, low C3: 0.7. C4<10, pancytopenia with platelet 82. patient was started on prednisolone 15 mg, and advised to seek urgent medical review if she felt unwell. In December 2017 she presented to ED generally unwell with worsening constitutional symptoms and drenching night sweats. Purpuric rash was see on both lower limbs. She had hair loss, no nail changes, no meningism or stigmata of infective endocarditis. Bloods showed worsening pancytopenia with Hb: 87, WCC: 3.9 N:3.04, Plt: 82, CRP: 46. Low c3 (0.70),c4 (<0.10). Normal U-E, LFTs persistently negative serology including ANA negative. Her urine dip was positive for bloods and protein with high urine PCR of 40. Lungs and pleural spaces were clear on chest x-ray. Infection screen including Heps serology, HIV: negative. A CT scan was organised to rule out mitotic lesions and showed mild pericardial effusion and bulky spleen with 24 x 15 mm ill-defined hypodense area at posterior border, possibly suggestive of small infarction. A small cystic lesion in the left adnexa was noted. No lymphadenopathy were noted. In view of pancytopenia, and ongoing constitutional symptoms we sought an inpatient haematology review which concluded that it is unlikley heamtological malignancy. The case was also discussed in hematology MDT with CT scan review. The probable working diagnosis at that point was vasculitis and to exclude cryoglobulineamia. The patient was discharged on 30mg of prednisolone. In January 2018 the patient was seen by haematology and felt reassured following the outocmnes of hematology MDT. She described feeling much better on 30mg of prednisolone. Constitutional symptoms i60 September 2018 CASE REPORTS
